Journal article
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
Abstract
BACKGROUND: Standard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or vitamin K antagonists. Limited data exists for alternate use of direct oral anticoagulants in children.
OBJECTIVES: The investigators aimed to obtain safety and efficacy data for edoxaban in children.
Authors
Portman MA; Jacobs JP; Newburger JW; Berger F; Grosso MA; Duggal A; Tao B; Goldenberg NA; Investigators E-AT; Brothers M
Journal
Journal of the American College of Cardiology, Vol. 80, No. 24, pp. 2301–2310
Publisher
Elsevier
Publication Date
December 2022
DOI
10.1016/j.jacc.2022.09.031
ISSN
0735-1097